Conversely, metabolic disturbances associated with obesity often exacerbate insulin resistance by modulating this pathway, which, via excessive insulin production in the pancreatic β-cells, leads to a vicious circle of glucose homeostasis impairment, ultimately resulting in hyperglycemia and the development of T2D [103]. The gene discussed is INS; the disease is obesity disorder.